Patent ID: 8992977
Filing Date: 2015-03-31
Classification: A61K,A61P

Abstract:
1. An oral pharmaceutical dosage form comprising a drug linked to a carrier by a spacer, wherein: (1) the drug is hydromorphone, zetia, lipitor, crestor, atacand, ethinyl estradiol, 17 beta-estradiol, levonorgestrel, norgestimate, norethisterone and rotigotine; (2) the carrier is pimozide, tamoxifen, fluoxetine, linoleic acid, zeaxanthin, eicosapentaenoic acid, chloroquine, or hydroxychloroquine; and (3) the spacer is hydrolyzable or enzymatically cleavable in the gastrointestinal tract of a patient ingesting the dosage form.